17-80107705-C-T

Variant summary

Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PP3PM2_SupportingPM3_StrongPP4_Moderate

This summary comes from the ClinGen Evidence Repository: The NM_000152.5:c.841C>T variant in GAA is predicted to result in the substitution of arginine by tryptophan at amino acid 281 (p.Arg281Trp). This variant has been reported in four individuals with features consistent with Pompe disease and documented GAA activity (PMID:36299500, clinical diagnostic laboratory - pseudodeficiency variants were ruled out) and another individual with features consistent with infantile onset Pompe disease on enzyme replacement therapy but GAA activity not provided (PMID:31086307). In addition, the variant was reported in an infant identified on newborn screen (PMID:33202836), as well as in five individuals reported to have later-onset disease (PMID:22081099, 33073009) (PP4_Moderate). Four patients are reported to be compound heterozygous for the variant and a pathogenic variant in GAA, including c.172C>T (p.Gln58Ter) (PMID:36299500, phase unknown) (ClinVar Variation ID: 188903; SCV001371756.1), c.2481+102_2646+31del (clinical diagnostic laboratory; phase unknown) (ClinVar Variation ID: 657307), c.2161delG (clinical diagnostic laboratory; confirmed in trans) (ClinVar Variation ID: 932900, SCV001371755.1), and c.-32-13T>G (PMID:33202836; phase unknown) (ClinVar Variation ID: 4027) (PM3_Strong). The score for the in silico meta-predictor REVEL, 0.786, suggests that the variant is deleterious, meeting PP3. The highest population minor allele frequency in gnomAD v2.1.1 is 0.00041 (European non-Finnish), meeting PM2_Supporting. To our knowledge, the results of functional studies are not available. There is a ClinVar entry for this variant (Variation ID: 283894). This variant meets the criteria to the classified as likely pathogenic for Pompe disease. The classification was first approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on December 5, 2019. Since then, the data for this variant have been re-evaluated - no new data were identified. The classification of likely pathogenic was reapproved on April 8, 2024. GAA-specific ACMG/AMP criteria met, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert Panel (Specifications Version 2.0): PM3_Strong, PP4_Moderate, PP3, PM2_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA8815025/MONDO:0009290/010

Frequency

Genomes: 𝑓 0.00031 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00054 ( 1 hom. )

Consequence

GAA
NM_000152.5 missense

Scores

9
9

Clinical Significance

Likely pathogenic reviewed by expert panel P:13U:5O:1

Conservation

PhyloP100: 2.23

Publications

14 publications found
Variant links:
Genes affected
GAA (HGNC:4065): (alpha glucosidase) This gene encodes lysosomal alpha-glucosidase, which is essential for the degradation of glycogen to glucose in lysosomes. The encoded preproprotein is proteolytically processed to generate multiple intermediate forms and the mature form of the enzyme. Defects in this gene are the cause of glycogen storage disease II, also known as Pompe's disease, which is an autosomal recessive disorder with a broad clinical spectrum. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
GAA Gene-Disease associations (from GenCC):
  • glycogen storage disease II
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine
  • glycogen storage disease due to acid maltase deficiency, infantile onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • glycogen storage disease due to acid maltase deficiency, late-onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 8 ACMG points.

PM2
For more information check the summary or visit ClinGen Evidence Repository.
PM3
For more information check the summary or visit ClinGen Evidence Repository.
PP3
For more information check the summary or visit ClinGen Evidence Repository.
PP4
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000152.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAA
NM_000152.5
MANE Select
c.841C>Tp.Arg281Trp
missense
Exon 4 of 20NP_000143.2P10253
GAA
NM_001079803.3
c.841C>Tp.Arg281Trp
missense
Exon 5 of 21NP_001073271.1P10253
GAA
NM_001079804.3
c.841C>Tp.Arg281Trp
missense
Exon 4 of 20NP_001073272.1P10253

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAA
ENST00000302262.8
TSL:1 MANE Select
c.841C>Tp.Arg281Trp
missense
Exon 4 of 20ENSP00000305692.3P10253
GAA
ENST00000390015.7
TSL:1
c.841C>Tp.Arg281Trp
missense
Exon 5 of 21ENSP00000374665.3P10253
GAA
ENST00000933406.1
c.841C>Tp.Arg281Trp
missense
Exon 4 of 20ENSP00000603465.1

Frequencies

GnomAD3 genomes
AF:
0.000313
AC:
47
AN:
150096
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000981
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000623
Gnomad OTH
AF:
0.000490
GnomAD2 exomes
AF:
0.000206
AC:
51
AN:
247128
AF XY:
0.000194
show subpopulations
Gnomad AFR exome
AF:
0.000187
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000415
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.000544
AC:
794
AN:
1460482
Hom.:
1
Cov.:
33
AF XY:
0.000546
AC XY:
397
AN XY:
726584
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33468
American (AMR)
AF:
0.00
AC:
0
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26116
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52336
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.000664
AC:
738
AN:
1111790
Other (OTH)
AF:
0.000878
AC:
53
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
53
107
160
214
267
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000306
AC:
46
AN:
150216
Hom.:
0
Cov.:
34
AF XY:
0.000287
AC XY:
21
AN XY:
73270
show subpopulations
African (AFR)
AF:
0.0000978
AC:
4
AN:
40892
American (AMR)
AF:
0.00
AC:
0
AN:
15076
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3458
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5080
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4732
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10288
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000608
AC:
41
AN:
67428
Other (OTH)
AF:
0.000484
AC:
1
AN:
2064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000396
Hom.:
0
Bravo
AF:
0.000317
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000206
AC:
25
EpiCase
AF:
0.000382
EpiControl
AF:
0.000415

ClinVar

ClinVar submissions
Significance:Likely pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
7
2
-
Glycogen storage disease, type II (10)
4
3
-
not provided (7)
1
-
-
Cardiovascular phenotype (1)
1
-
-
GAA-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.51
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Pathogenic
0.37
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.44
T
Eigen
Uncertain
0.59
Eigen_PC
Uncertain
0.42
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.97
D
M_CAP
Pathogenic
0.47
D
MetaRNN
Pathogenic
0.83
D
MetaSVM
Pathogenic
0.95
D
MutationAssessor
Pathogenic
4.2
H
PhyloP100
2.2
PrimateAI
Uncertain
0.66
T
PROVEAN
Pathogenic
-6.4
D
REVEL
Pathogenic
0.79
Sift
Uncertain
0.0010
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.95
MVP
1.0
MPC
0.55
ClinPred
0.98
D
GERP RS
2.8
Varity_R
0.94
gMVP
0.95
Mutation Taster
=63/37
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142967546; hg19: chr17-78081504; COSMIC: COSV56409042; COSMIC: COSV56409042; API